Celltrion launches Remicade biosimilar in Europe

Celltrion Inc. (KOSDAQ:068270) launched Remsima infliximab ( CT-P13) in 12 European countries including Austria, Belgium, Denmark,

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE